Bacteriophage therapy successfully treats patient's multidrug-resistant Pseudomonas aeruginosa knee wound
Why in news: Researchers at SHRI Hospital reported the successful treatment of a multidrug-resistant Pseudomonas aeruginosa knee wound using bacteriophage therapy.
The therapy was developed by Dr. Sutharsan Govindarajan (SRM University-A.P.) with support from researchers at Ipseity Diagnostics and Research. The successful clinical outcome was published in the journal IJID Regions on October 22, 2026.
Prelims pointers (2)
- FactPseudomonas aeruginosa: A bacterium known for causing multidrug-resistant infections.
- PostDr. Kalyan Chakravarthy Koganti: Researcher at SHRI Hospital who reported the successful treatment.
Mains angle
Q. Discuss the potential of bacteriophage therapy as a viable alternative to conventional antibiotics in tackling the global crisis of antimicrobial resistance.
- Regulatory hurdle: Lack of standardized clinical protocols for phage-based therapeutics
- Specificity advantage: Ability of phages to target pathogens without harming beneficial microbiota
- Resistance evolution: Potential for bacteria to develop resistance to specific bacteriophage strains
Keywords: Antimicrobial Resistance · Bacteriophage Therapy · Biotechnology · Clinical Efficacy · Pathogen Specificity